GHRP-6 5mg ×10 + MOD-GRF (1-29) 5mg ×10 (Bundle)
CAS: 87616-84-0 / 86168-78-7
The GHRP-6 & MOD-GRF (1-29) 5mg ×10 Bundle by BioPeptides is a high-purity research peptide combination designed for advanced laboratory studies in growth hormone signaling, receptor coordination, and endocrine pathway analysis. Produced using precision solid-phase peptide synthesis (SPPS) and purified to ≥99% HPLC, this dual-peptide bundle enables researchers to investigate ghrelin-mediated and GHRH-mediated signaling pathways in controlled in-vitro experimental environments.
$1250.00
Research Use Only
Research Overview
The GHRP-6 & MOD-GRF (1-29) bundle is designed for advanced laboratory research into growth hormone release mechanisms and endocrine signaling pathways.
GHRP-6 is a growth hormone secretagogue peptide studied for its interaction with the ghrelin receptor (GHS-R).
MOD-GRF (1-29) is a truncated analog of Growth Hormone Releasing Hormone (GHRH) that activates pituitary GH signaling pathways.
Studying these peptides together allows researchers to examine receptor coordination, signal amplification, and endocrine feedback mechanisms.
Scientific Background
Growth hormone release in endocrine systems is regulated through multiple receptor-mediated signaling pathways.
GHRP-6 stimulates ghrelin receptors which influence GH secretion signaling.
MOD-GRF (1-29) activates GHRH receptors at the pituitary level.
Together these peptides allow researchers to analyze how distinct receptor systems coordinate endocrine signaling responses.
Mechanistic Research Perspective
- Ghrelin receptor (GHS-R) activation analysis
- Growth hormone releasing hormone receptor signaling
- Endocrine feedback loop investigation
- Hormonal pathway coordination studies
- Ligand-receptor interaction modeling
Primary Research Applications
Growth Hormone Release Dynamics: Researchers study GH secretion patterns, receptor activation timing, and endocrine signaling efficiency.
Endocrine Pathway Coordination: The peptide combination enables investigation of how ghrelin-based and GHRH-based signaling pathways interact.
Receptor Cross-Talk Research: Scientists analyze signaling integration between ghrelin receptors and GHRH receptors.
Cellular Signaling Research: Used in cell-based experiments investigating intracellular hormonal signaling cascades.
In-Vitro Research Models: The bundle is frequently used in non-clinical laboratory models studying endocrine receptor signaling.
Molecular Characteristics
- Peptide Type: Growth hormone signaling peptides
- GHRP-6 CAS: 87616-84-0
- MOD-GRF (1-29) CAS: 86168-78-7
- Form: Lyophilized peptide powder
- Purity: ≥99% HPLC verified
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C
- Protect from moisture and light exposure
- Avoid repeated freeze–thaw cycles
- Reconstituted solutions should be refrigerated
- Handle under aseptic laboratory conditions
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Sterile saline solution
- Buffered aqueous solutions
- Biochemical assay buffers
- Laboratory-grade solvent systems
Technical Specifications
product Name
GHRP-6 + MOD-GRF (1-29) Bundle
brand
BioPeptides
cas
87616-84-0 / 86168-78-7
purity
≥99% (HPLC verified)
unit Size
5mg ×10 vials each
form
Lyophilized peptide powder
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry
molecular Structure
Synthetic peptide hormones
stability
High when stored at −20°C
Analytical Validation and Quality Assurance
- High-performance liquid chromatography purity verification
- Mass spectrometry molecular weight confirmation
- Peptide structural integrity testing
- Batch-to-batch analytical consistency
- Peptide stability validation
Frequently Asked Questions
The bundle allows researchers to study growth hormone signaling through two complementary receptor pathways, enabling analysis of signal initiation, amplification, and endocrine pathway coordination.
MOD-GRF (1-29) is a truncated GHRH analog that produces controlled receptor activation and allows precise investigation of endocrine signaling dynamics.
Yes. The 5mg ×10 vial format allows extended research protocols while reducing peptide degradation risk.
Yes. Researchers often compare ghrelin-mediated signaling and GHRH-mediated signaling using this peptide pairing.
GHRP-6 is studied for its distinct ghrelin receptor interaction and signaling profile, making it valuable for comparative studies alongside other GH secretagogues.
Yes. Each peptide is supplied in individual 5mg vials, improving stability, supporting precise experimental design, and minimizing freeze-thaw exposure.
Lyophilized vials should be stored at -20°C, reconstituted only with sterile laboratory solvent, and protected from repeated freeze-thaw cycles to maintain stability.
BioPeptides is trusted for high-purity synthesis, verified CAS documentation, consistent batch quality, and strict adherence to European research standards.